Kaleido Biosciences, Inc. (KLDO)
Develops medicines that modify gut bacteria to treat diseases like liver and digestive disorders
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+0.0%
The outlook
KLDO is trading at the extreme bottom of its 52-week range and well below both its 50- and 200-day moving averages, indicating a prolonged downtrend. The stock shows minimal analyst activity, making current sentiment difficult to gauge from coverage alone. Current data reflects deeply depressed price action with no recent upside momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$4,262
52-wk high
$0.20
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—